Connect with us


EMA recommends Novavax COVID vaccine for adolescents




We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

Novavax logo and two Vials labeled "VACCINE Coronavirus Covid-19".

Thursday's (23 June) advisory committee to the European Union drug regulator recommended that Novavax Inc's COVID-19 vaccine be expanded for adolescents 12-17 years old.

Share this article:

EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter.